Clinical trial
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol…
NCT00447863 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00447863 |
|---|---|
| Title | Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women |
| Official title | An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study to Compare Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg in 2 Dosage Forms With Different Dissolution Characteristics in Healthy, Cycling Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Levonorgestrel/Ethinyl Estradiol |
| Enrollment | 0 |
| Start date | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Mar 15, 2007 |
| Last update posted | Aug 20, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: